Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why [Yahoo! Finance]
Can This Stock Double Again in 2026? [Yahoo! Finance]
H.C. Wainwright Upgrades Structure Therapeutics (GPCR) on Massive Arbitrage Opportunity for Oral GLP-1 [Yahoo! Finance]
Structure Therapeutics (NASDAQ:GPCR) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Structure Therapeutics (GPCR) valuation check after Phase 1 obesity candidate ACCG-2671 enters first-in-human trial [Yahoo! Finance]